IBDEI225 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,997,0)
 ;;=PAIN^19^84
 ;;^UTILITY(U,$J,358.4,998,0)
 ;;=SUTURES/DRESSINGS^28^84
 ;;^UTILITY(U,$J,358.4,999,0)
 ;;=COMPLICATIONS^4^84
 ;;^UTILITY(U,$J,358.4,1000,0)
 ;;=SLEEP DISORDERS^27^84
 ;;^UTILITY(U,$J,358.4,1001,0)
 ;;=COMMON PULMONARY DX^1^84
 ;;^UTILITY(U,$J,358.4,1002,0)
 ;;=CVA LATE EFFECTS^5^84
 ;;^UTILITY(U,$J,358.4,1003,0)
 ;;=SCI/PARALYTIC SYNDROMES^23^84
 ;;^UTILITY(U,$J,358.4,1004,0)
 ;;=IMMUNIZATIONS/INJECTIONS^4^85
 ;;^UTILITY(U,$J,358.4,1005,0)
 ;;=RESPIRATORY^8^85
 ;;^UTILITY(U,$J,358.4,1006,0)
 ;;=SLEEP STUDIES^9^85
 ;;^UTILITY(U,$J,358.4,1007,0)
 ;;=PULMONARY FUNCTION TESTS^7^85
 ;;^UTILITY(U,$J,358.4,1008,0)
 ;;=OTHER^5^85
 ;;^UTILITY(U,$J,358.4,1009,0)
 ;;=ABG^1^85
 ;;^UTILITY(U,$J,358.4,1010,0)
 ;;=OXYGEN CLINIC^6^85
 ;;^UTILITY(U,$J,358.4,1011,0)
 ;;=CPAP^2^85
 ;;^UTILITY(U,$J,358.4,1012,0)
 ;;=EDUCATION/TRAINING GRP/IND^3^85
 ;;^UTILITY(U,$J,358.4,1013,0)
 ;;=SUPPLIES^10^85
 ;;^UTILITY(U,$J,358.4,1014,0)
 ;;=ESTABLISHED PT-OUTPT^1^86
 ;;^UTILITY(U,$J,358.4,1015,0)
 ;;=INPATIENT CARE^2^86
 ;;^UTILITY(U,$J,358.4,1016,0)
 ;;=SIGNS & SYMPTOMS^24^87
 ;;^UTILITY(U,$J,358.4,1017,0)
 ;;=ENDOCRINE & METABOLIC^6^87
 ;;^UTILITY(U,$J,358.4,1018,0)
 ;;=HEMATOLOGIC & LYMPHATIC^10^87
 ;;^UTILITY(U,$J,358.4,1019,0)
 ;;=EYES, EARS & NOSE^7^87
 ;;^UTILITY(U,$J,358.4,1020,0)
 ;;=VASCULAR^29^87
 ;;^UTILITY(U,$J,358.4,1021,0)
 ;;=MUSCULOSKELETAL^14^87
 ;;^UTILITY(U,$J,358.4,1022,0)
 ;;=GENITOURINARY & RENAL^9^87
 ;;^UTILITY(U,$J,358.4,1023,0)
 ;;=CARDIAC^3^87
 ;;^UTILITY(U,$J,358.4,1024,0)
 ;;=INTERSTITIAL LUNG DISEASES^13^87
 ;;^UTILITY(U,$J,358.4,1025,0)
 ;;=OCCUPATIONAL^17^87
 ;;^UTILITY(U,$J,358.4,1026,0)
 ;;=OTHER^18^87
 ;;^UTILITY(U,$J,358.4,1027,0)
 ;;=PLEURAL DISEASE^20^87
 ;;^UTILITY(U,$J,358.4,1028,0)
 ;;=INFECTIOUS DISEASES^12^87
 ;;^UTILITY(U,$J,358.4,1029,0)
 ;;=NEUROMUSCULAR/SKELETAL^16^87
 ;;^UTILITY(U,$J,358.4,1030,0)
 ;;=GASTROINTESTINAL^8^87
 ;;^UTILITY(U,$J,358.4,1031,0)
 ;;=HEPATIC & BILIARY^11^87
 ;;^UTILITY(U,$J,358.4,1032,0)
 ;;=NEUROLOGIC^15^87
 ;;^UTILITY(U,$J,358.4,1033,0)
 ;;=SKIN^26^87
 ;;^UTILITY(U,$J,358.4,1034,0)
 ;;=PSYCHIATRIC & BEHAVIORAL^21^87
 ;;^UTILITY(U,$J,358.4,1035,0)
 ;;=CANCER^2^87
 ;;^UTILITY(U,$J,358.4,1036,0)
 ;;=RADIATION^22^87
 ;;^UTILITY(U,$J,358.4,1037,0)
 ;;=SKELETAL^25^87
 ;;^UTILITY(U,$J,358.4,1038,0)
 ;;=PAIN^19^87
 ;;^UTILITY(U,$J,358.4,1039,0)
 ;;=SUTURES/DRESSINGS^28^87
 ;;^UTILITY(U,$J,358.4,1040,0)
 ;;=COMPLICATIONS^4^87
 ;;^UTILITY(U,$J,358.4,1041,0)
 ;;=SLEEP DISORDERS^27^87
 ;;^UTILITY(U,$J,358.4,1042,0)
 ;;=COMMON PULMONARY DX^1^87
 ;;^UTILITY(U,$J,358.4,1043,0)
 ;;=CVA LATE EFFECTS^5^87
 ;;^UTILITY(U,$J,358.4,1044,0)
 ;;=SCI/PARALYTIC SYNDROMES^23^87
 ;;^UTILITY(U,$J,358.4,1045,0)
 ;;=SCREENING FOR MENTAL/DEVELOPMENT^25^88
 ;;^UTILITY(U,$J,358.4,1046,0)
 ;;=PERSONAL HX OF MALIGNANCY^22^88
 ;;^UTILITY(U,$J,358.4,1047,0)
 ;;=ACQUIRED ABSENCE OF ORGAN^2^88
 ;;^UTILITY(U,$J,358.4,1048,0)
 ;;=PERSONS SEEKING CONSULT^23^88
 ;;^UTILITY(U,$J,358.4,1049,0)
 ;;=FAMILY CIRCUMSTANCES^9^88
 ;;^UTILITY(U,$J,358.4,1050,0)
 ;;=FAMILY HX OF MALIGNANCY^11^88
 ;;^UTILITY(U,$J,358.4,1051,0)
 ;;=FAMILY HX OF CHR DISABILITY^10^88
 ;;^UTILITY(U,$J,358.4,1052,0)
 ;;=PERSONAL HX OF HAZARDS TO HEALTH^21^88
 ;;^UTILITY(U,$J,358.4,1053,0)
 ;;=FAMILY HX OF SPECIFIC CONDITION^13^88
 ;;^UTILITY(U,$J,358.4,1054,0)
 ;;=FAMILY HX OF OTHER CONDITION^12^88
 ;;^UTILITY(U,$J,358.4,1055,0)
 ;;=MENTAL AND BEHAVIORAL PROBLEMS^15^88
 ;;^UTILITY(U,$J,358.4,1056,0)
 ;;=ORGAN OR TISSUE REPLACED^16^88
 ;;^UTILITY(U,$J,358.4,1057,0)
 ;;=PERSONAL HX OF CERTAIN DX^20^88
 ;;
 ;;$END ROU IBDEI225
